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Purpose: Suprapubic bladder aspiration is an invasive procedure in which a needle is used to obtain a urine sample
directly from the bladder. Its advantages are sensitivity (detection of signiﬁcant bacteriuria is close to 100%),
suitability for cultivation of anaerobic bacteria, and low risk of contamination. Our purpose was to characterize the
microbiology and epidemiology of urine samples obtained through this procedure in the Clinical Center of
the University of Szeged’s Institute of Clinical Microbiology between 2008 and 2017. Materials and methods:
Over the 10-year period, patient data were collected and suprapubic bladder aspirations were performed, and the
samples are processed in accordance with routine laboratory procedures in clinical bacteriology. Results:Of 187 urine
samples obtained from 148 patients, 32.6% (n= 61) were culture-positive (deﬁned as 102 colony forming units/ml or
more). Conclusions: This method should be considered an important sampling procedure in the differential
diagnostics of upper urinary tract infections, particularly in children <2 years of age, and in older people, hospitalized
patients.
Keywords: suprapubic bladder aspiration, urinary tract infections, upper UTIs, epidemiology, matrix-assisted laser
desorption/ionization–time-of-ﬂight
INTRODUCTION
Suprapubic bladder aspiration (i.e., a bladder tap, as ﬁrst
described by Guze & Beeson [1]) is an invasive procedure in
which a needle is used to obtain a urine sample directly from
the bladder [2]. The advantages of this method include its
sensitivity (detection of signiﬁcant bacteriuria is close to
100%), suitability for cultivation of anaerobic bacteria, and
low risk of contamination [2, 3]. In this study, we present the
culture results and related epidemiology of urine samples
obtained through this procedure in a teaching hospital in
Hungary from 2008 to 2017.
MATERIALS AND METHODS
This study was carried out with the cooperation of the
University of Szeged’s Institute of Clinical Microbiology and
the Albert Szent-Györgyi Clinical Center, a 1,820-bed
teaching hospital providing primary and tertiary care for the
urban and rural population in Csongrád County, Hungary. We
performed a retrospective microbiological characterization of
urine samples obtained through suprapubic bladder aspiration
at the Clinical Center over a 10-year period (between January
1, 2008 and December 31, 2017). Patient data were collected,
limited to demographic characteristics (age and gender) and
the indication for sample submission [4].
Urine samples were processed in accordance with routine
procedures in clinical bacteriology [5]. Facultative anae-
robes were cultivated using UriSelect chromogenic agar
plates (Bio-Rad, Berkeley, CA, USA) at 37 °C in a 5%
CO2 atmosphere. As per request of the clinicians, some of
the urine samples were also cultivated anaerobically, with
the help of an anaerobic chamber (Baker Ruskinn, York,
UK), in an atmosphere of 90% N2, 5% H2, and 5% CO2 at
37 °C. Between 2008 and 2012, bacterial isolates were
identiﬁed based on presumptive (biochemical) methods and
VITEK 2 Compact ID (facultative anaerobes) and ANC
(strict anaerobes) cards (bioMérieux Hungária Ltd.,
Budapest, Hungary). From 2012 onward, they were identi-
ﬁed using matrix-assisted laser desorption/ionization–time-
of-ﬂight mass spectrometry, using the Microﬂex MALDI
Biotyper (Bruker Daltonics, Bremen, Germany). The meth-
odology of sample preparation for mass spectrometry
measurements was described elsewhere [6]. Facultative anae-
robes were tested for antibiotic susceptibility using the disk
diffusion method on Mueller–Hinton agar plates, whereas
anaerobic isolates were tested using E-test (Lioﬁlchem,
Abruzzo, Italy) on Brucella blood agar (BBA, Oxoid,
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Basingstoke, UK) supplemented with 5% laked sheep blood,
hemin, and vitamin K [7]. Interpretation of the susceptibility
results and detection of resistance mechanisms were based on
EUCAST guidelines (http://www.eucast.org/). Descriptive
statistical analysis (including means or medians with ranges
and percentages to characterize data) was performed using
Microsoft Excel 2013 (Microsoft Corp., Redmond, WA,
USA).
RESULTS
A total of 187 urine samples (18.7± 8.4/year; range: 4–29;
lowest in 2014, highest in 2017), obtained through supra-
pubic bladder aspiration from 148 patients, were received
during the study period (2008–2017). During that 10-year
period, the Institute received 19,325 samples from inpatient
departments and 21,150 samples from outpatient clinics of
the Albert Szent-Györgyi Clinical Center; therefore, 0.5% of
urine samples were obtained through suprapubic bladder
aspiration [8]. The patients had an average age of 33.4 years
(median: 11; range: 0–84) and a male-to-female ratio of 1.88
(65.2% male). Most affected patients were younger than
5 (41.7%) years or older than 50 (39.4%) years. Most of the
samples (95.9%) were originated from the Departments of
Pediatrics (54.6%), Internal Medicine (20.7%), Urology
(15.5%), and the Intensive Care Unit (5.1%). The indica-
tions for sample submission (based on the submission forms
provided with the samples) were mainly related to disorders
of the urinary system (87.7%); these included congenital
abnormalities, suspicions of urinary tract infections (UTIs),
kidney stones, or malignancy and renal failure. The other
indications (12.3%) were traumatic injuries, septicaemia,
and stroke.
Overall, 32.6% of the samples (n = 61) were culture-
positive (deﬁned as 102 colony forming units/ml or more),
which is in line with data in the literature for culture
positivity of urine samples (10%–50%) and the results in
our Institute for conventionally collected urine samples
(∼34%–38%; for these samples, culture positivity is usu-
ally deﬁned as 105 or more colony forming units/ml) [8, 9].
In the positive urine samples, the following species were
isolated in the order of decreasing frequency: Enterococcus
faecalis (n = 14), Escherichia coli (n = 10), Klebsiella
pneumoniae (n = 8), Pseudomonas aeruginosa (n = 8),
Proteus vulgaris (n = 6), Enterococcus faecium and Staph-
ylococcus aureus (n = 3 each), Enterobacter cloacae,
Candida albicans, Candida tropicalis, and Proteus
mirabilis (n = 2 each), and Klebsiella oxytoca (n = 1). In
addition, 28.9% (n = 54) of the samples were cultivated
anaerobically, per request of the treating physician, and
three more species were isolated, such as Finegoldia
magna (n = 2), Peptococcus niger, and Peptinophilus
indolicus (n = 1 each). None of the positive samples in-
cluded more than one isolate. Multidrug-resistant (MDR)
pathogens were recovered from 11 samples (18.0%),
namely, the extended-spectrum β-lactamase producing E.
coli (n = 5), K. pneumoniae (n = 3), and E. cloacae (n = 1),
the vancomycin-resistant E. faecium (n = 1), and the meth-
icillin-resistant S. aureus (n = 1). The susceptibilities of the
remaining pathogens were unremarkable.
DISCUSSION
In this study, we characterized the microbiology and epide-
miology of urine samples obtained between 2008 and 2017
through suprapubic aspiration of the bladder of patients in the
southern region of Hungary. This was the ﬁrst such study in
Hungary and the longest-spanning study of its kind overall.
The main indications for the suprapubic aspiration method
included urinary retention (e.g., due to hyperplasia or tumours
of the prostate, gynaecological malignancies, or spinal cord
injuries) and constriction, phimosis, and chronic (therapy-
resistant) infections or congenital abnormalities of the urinary
system in young children and older adults [10]. In addition,
this sampling method may be used in the diagnosis of lower
UTIs, where obtaining a sample voluntarily or through
catheterization is not possible [2, 10]. With the appropriate
equipment (disinfectant, local anaesthetic, 22-gauge spinal
needle, syringe, and sterile collection container) and clinical
experience, obtaining the sample is a relatively simple proce-
dure and provides clinically relevant information [11]. Nev-
ertheless, as it is an invasive sampling procedure, some
disadvantages (fear of the patient, pain, and discomfort) and
possible complications (haematuria, bleeding, visceral
injuries, and hemoperitoneum in severe cases) should be
considered [12].
Interestingly, one out of six isolates in this study was
MDR. This may present serious therapeutic challenges for
clinicians, as they will not only have to consider the
pharmacokinetics of the drugs appropriate for these
infections, but they will also have a limited drug armamen-
tarium due to the resistance [13, 14]. There is no known
pathological mechanism or epidemiological evidence in the
literature to explain the accumulation of MDR strains in
these infections. During the 10-year study period, several
anaerobic species were detected from bladder tap samples,
presumably corresponding to chronic upper UTIs. The latter
ﬁnding is especially interesting, as there is mounting
evidence that anaerobes may be signiﬁcant pathogens in
UTIs; however, because urine samples are not routinely
cultured in an anaerobic environment, more studies (espe-
cially employing molecular biological methods or sequenc-
ing) are needed to ascertain the real clinical role of these
microorganisms [2, 3, 9]. Among other anaerobes, Actino-
tignum schaalii (formerly known as Actinobaculum, ﬁrst
described in 1997) has received substantial attention as an
important urinary tract pathogen in elderly patients or in
people with underlying urological pathologies [15]. This
Gram-positive bacterium (as are other anaerobes in the
urinary tract) is often overlooked. Relevant urine samples
are usually present with a negative nitrite test and signiﬁcant
leukocyturia; molecular methods may also be used, but for
veriﬁcation of infection, cultivation of the sample in strict
anaerobic conditions is a compulsory [16].
CONCLUSIONS
Suprapubic bladder aspiration should be considered as an
important sampling procedure in the differential diagnostics
of upper UTIs, particularly in children <2 years of age
(where conventional sampling methods may prove
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ineffective), in older people, hospitalized patients, or if
chronic infections caused by anaerobes are suspected.
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